Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial

• Principais autores: Mustafa Erelel (Autor), Mert Kaskal (Autor), Ozlem Akbal-Dagistan (Autor), Halim Issever (Autor), Ahmet Serhan Dagistanli (Autor), Hilal Balkanci (Autor), Merve Sinem Oguz (Autor), Aygun Qarayeva (Autor), Meltem Culha (Autor), Aybige Erturk (Autor), Nur Sena Basarir (Autor), Gokben Sahin (Autor), Ali Yagiz Uresin (Autor), Ahmet Ogul Araman (Autor), Alpay Medetalibeyoglu (Autor), Tufan Tukek (Autor), Mustafa Oral Oncul (Autor), Ayca Yildiz-Pekoz (Autor)
• Formato: Livro
• Publicado em: MDPI AG, 2021-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

In COVID-19-induced acute respiratory distress syndrome, the lungs are incapable of filling with sufficient air, leading to hypoxemia that results in high mortality among hospitalized patients. In clinical trials, low-molecular-weight heparin was administered via a specially designed soft-mist inhal...